<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Haematopoiesis can be interpreted as an ecosystem composed of billions of cells interacting according to Darwinian rules </plain></SENT>
<SENT sid="1" pm="."><plain>Mutation, by promoting cell diversity, ensures versatility in coping with internal and external challenges </plain></SENT>
<SENT sid="2" pm="."><plain>Most mutated cells are eliminated through <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>However, if mutation generates relative resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> it may result in growth advantage for the mutated cells </plain></SENT>
<SENT sid="4" pm="."><plain>The probability of monoclonality and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> is significantly increased if the <z:mpath ids='MPATH_458'>normal</z:mpath> multiclonal environment is damaged by a pathologic proapoptotic process that spares the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> resistant clones </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0024790" disease_type="Disease or Syndrome" abbrv="PNH">Paroxysmal nocturnal haemoglobinuria</z:e>, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath>, secondary <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemias</z:mpath> and immunosuppression-related non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> can be interpreted as 'opportunistic' clonal and malignant diseases </plain></SENT>
<SENT sid="6" pm="."><plain>Free radicals (FRs) are closely linked to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and have been incriminated in <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Conditions associated with increased FR formation or impaired FR disposal may provide the enhanced apoptotic background against which an <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-resistant clone may gain growth advantage </plain></SENT>
</text></document>